Inverse Changes in Quality of Life for Patients and Caregivers After Implantation of a Ventricular Assist Device

Abstract

Ventricular Assist Device (VAD) implantation is emerging as a main therapeutic option for patients with advanced heart failure (HF). In order to be eligible for VAD therapy, most centers require that patients designate a primary informal caregiver to assist with post-operative recovery, device management, and HF self-care. Although implantation typically results in improvements in quality of life (QOL) for the patient, little is known quantitatively about post-implantation changes in QOL for the caregiver.